A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases
Clinical trial NCT06076642 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06076642
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-04
- Primary completion
- 2028-05-16
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.